4.1 Article

C. ELEGANS MODELS OF NEUROMUSCULAR DISEASES EXPEDITE TRANSLATIONAL RESEARCH

Journal

TRANSLATIONAL NEUROSCIENCE
Volume 1, Issue 3, Pages 214-227

Publisher

DE GRUYTER POLAND SP ZOO
DOI: 10.2478/v10134-010-0032-9

Keywords

Caenorhabditis elegans; Neuromuscular disease; Drug screening; Duchenne muscular dystrophy Spinal muscular atrophy; Amyotrophic lateral sclerosis

Categories

Funding

  1. Functional Genomics Unit of the Medical Research Council of the UK
  2. MRC [G0801760] Funding Source: UKRI
  3. Medical Research Council [G0801760] Funding Source: researchfish

Ask authors/readers for more resources

The nematode Caenorhabditis elegans is a genetic model organism and the only animal with a complete nervous system wiring diagram. With only 302 neurons and 95 striated muscle cells, a rich array of mutants with defective locomotion and the facility for individual targeted gene knockdown by RNA interference, it lends itself to the exploration of gene function at nerve muscle junctions. With approximately 60% of human disease genes having a C. elegans homologue, there is growing interest in the deployment of low-cost, high-throughput, drug screens of nematode transgenic and mutant strains mimicking aspects of the pathology of devastating human neuromuscular disorders. Here we explore the contributions already made by C. elegans to our understanding of muscular dystrophies (Duchenne and Becker), spinal muscular atrophy, amyotrophic lateral sclerosis, Friedreich's ataxia, inclusion body myositis and the prospects for contributions to other neuromuscular disorders. A bottleneck to low-cost, in vivo, large-scale chemical library screening for new candidate therapies has been rapid, automated, behavioural phenotyping. Recent progress in quantifying simple swimming (thrashing) movements is making such screening possible and is expediting the translation of drug candidates towards the clinic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available